{"id":46369,"date":"2012-06-05T01:20:02","date_gmt":"2012-06-05T01:20:02","guid":{"rendered":"http:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/uncategorized\/atossa-genetics-to-participate-in-5th-national-breast-centers-of-excellence-conference-in-dallas-texas.php"},"modified":"2012-06-05T01:20:02","modified_gmt":"2012-06-05T01:20:02","slug":"atossa-genetics-to-participate-in-5th-national-breast-centers-of-excellence-conference-in-dallas-texas","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/health-care\/atossa-genetics-to-participate-in-5th-national-breast-centers-of-excellence-conference-in-dallas-texas.php","title":{"rendered":"Atossa Genetics to Participate in 5th National Breast Centers of Excellence Conference in Dallas, Texas"},"content":{"rendered":"<p><p>    SEATTLE, WA--(Marketwire -06\/04\/12)- Atossa Genetics, Inc., a    privately-held health care company focused on the prevention of    breast    cancer through the commercialization of diagnostic tests    that can detect precursors to breast cancer, and through the    research, development, and ultimate commercialization of    treatments for pre-cancerous breast lesions, today announced    that Steven C.    Quay, M.D., Ph.D., FCAP, Chairman, President & CEO    of     Atossa Genetics and Director of the     National Reference Laboratory for Breast Health, will    conduct a workshop at Active Communications International's        5th National Breast Centers of Excellence conference, June    6-8, 2012, in Dallas, Texas.  <\/p>\n<p>    The workshop, titled \"Using Unique Molecular Tests to Grow Your    Breast Center of Excellence Patient Base,\" will take place on    Friday, June 8, from 2:15-3:15 pm Central Time. Workshop    attendees will learn how to:  <\/p>\n<p>    \"I am pleased to have the opportunity to conduct a workshop on    molecular tests at this prestigious event,\" stated Steven C.    Quay, M.D., Ph.D., FCAP, Chairman, President and CEO of Atossa    Genetics and Director of the National Reference Laboratory for Breast    Health. \"Our suite of new molecular tests can provide    Breast Centers of Excellence with a unique offering to help set    them apart in their local markets. By partnering with a    national reference laboratory for breast health, Breast Centers    of Excellence can show their commitment to best practice and    can set the stage for their participation with the next    generation of breast cancer prevention, intraductal    pharmaceutical treatment of DCIS and related pre-cancerous    lesions.\"  <\/p>\n<p>    About Atossa Genetics, Inc.  <\/p>\n<p>    Atossa Genetics, Inc. is a privately held health care company    based in Seattle, Washington, that provides a comprehensive set    of innovative breast health evaluation products and services    that provide accurate and actionable results for personalized    cancer prevention and breast health. Atossa has established the    National Reference Laboratory for Breast Health, a specially    equipped,     CLIA-certified laboratory located in Seattle that provides    comprehensive test results to guide personalized breast cancer    prevention and treatment solutions.  <\/p>\n<p>    About the National Reference Laboratory for Breast    Health  <\/p>\n<p>    The National Reference Laboratory for Breast Health, a division    of Atossa Genetics, Inc., is focused on developing novel,    clinically relevant tests for evaluating Breast Health in all    women. The National Reference Laboratory for Breast Health,    located in Seattle, Washington, is the only CLIA-registered    laboratory focused exclusively on breast health. The National    Reference Laboratory for Breast Health provides comprehensive    test results to guide personalized breast cancer prevention and    treatment solutions. For additional information on the ForeCYTE    Breast Health Test and the ArgusCYTE Breast Health Test, please    visit     <a href=\"http:\/\/www.NRLBH.com\" rel=\"nofollow\">http:\/\/www.NRLBH.com<\/a>.  <\/p>\n<p>    About the Breast Center of Excellence Designation  <\/p>\n<p>    The     Breast Imaging Center of Excellence (BICOE) designation is    awarded to breast imaging centers that achieve excellence by    seeking and earning accreditation in all of the American    College of Radiology's voluntary breast-imaging accreditation    programs and modules, in addition to the mandatory Mammography    Accreditation Program.  <\/p>\n<\/p>\n<p>Originally posted here: <\/p>\n<p><a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/atossa-genetics-participate-5th-national-180000294.html;_ylt=A2KLOzGjXs1PQUUAh4H_wgt.\" title=\"Atossa Genetics to Participate in 5th National Breast Centers of Excellence Conference in Dallas, Texas\">Atossa Genetics to Participate in 5th National Breast Centers of Excellence Conference in Dallas, Texas<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> SEATTLE, WA--(Marketwire -06\/04\/12)- Atossa Genetics, Inc., a privately-held health care company focused on the prevention of breast cancer through the commercialization of diagnostic tests that can detect precursors to breast cancer, and through the research, development, and ultimate commercialization of treatments for pre-cancerous breast lesions, today announced that Steven C. Quay, M.D., Ph.D., FCAP, Chairman, President &#038; CEO of Atossa Genetics and Director of the National Reference Laboratory for Breast Health, will conduct a workshop at Active Communications International's 5th National Breast Centers of Excellence conference, June 6-8, 2012, in Dallas, Texas <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/health-care\/atossa-genetics-to-participate-in-5th-national-breast-centers-of-excellence-conference-in-dallas-texas.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[6],"tags":[],"class_list":["post-46369","post","type-post","status-publish","format-standard","hentry","category-health-care"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/46369"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=46369"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/46369\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=46369"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=46369"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=46369"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}